or
forgot password
  • cancer clinical trials in chapel hill, NC

  • Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial
    University of North Carolina at Chapel Hill General Medicine Clinic

    Trial Locations
    University of North Carolina at Chapel Hill General Medicine Clinic
    Chapel Hill North General Internal Medicine Practice
    Prostatic Neoplasms
    Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599-7305
    Breast Cancer
    A Couples Approach to Enhance Breast Cancer Survivorship
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Early-Stage Breast Cancer
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Leukemia, Acute Leukemia, Acute Lymphocytic Leukemia, Multiple Myeloma, Hematological Cancers, Psychological Distress
    Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer
    Site Reference ID/Investigator# 11341
    Chapel Hill, North Carolina 27599-7305
    Advanced Colorectal Cancer, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
    A Study of Alvimopan for the Management of Postoperative Ileus in Subjects Undergoing Radical Cystectomy
    University of North Carolina Hospitals
    Chapel Hill, North Carolina 27599
    Postoperative Ileus
    A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
    UNC Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina
    Hepatocellular Carcinoma
    Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Breast Cancer, Nausea and Vomiting
    Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Leukemia
    Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Liver Cancer
    Pounds Off Digitally Study: A Podcasting Weight Loss Intervention
    UNC-Chapel Hill
    Chapel Hill, North Carolina 27599
    Weight Loss
    Digital Breast Tomosynthesis Preference Study
    Breast Imaging Clinic; University of North Carolina Hospitals
    Chapel Hill, North Carolina 27514
    Breast Cancer
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Ulcerative Colitis
    CMX001 in Post-transplant Patients With BK Virus Viruria
    UNC Kidney Center
    Chapel Hill, North Carolina 27599
    Viruria
    Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) (The STAR Study)
    University of North Carolina Hospitals
    Chapel Hill, North Carolina 27599
    Thrombotic Thrombocytopenic Purpura
    Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Anemia, Sickle Cell
    Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Brain Diseases, Spinal Cord Diseases
    Alternate Dosing Schedules Study for HPV Vaccine
    Chapel Hill Pediatrics
    Chapel Hill, North Carolina 27514
    Cervical Cancer, Genital Warts
    ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension
    Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Breast Cancer
    Colon Cancer Prevention Study
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Colorectal Cancer
    Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer
    UNC/ Lineberger Comprehensive Cancer Center Dept. of Linberger Cancer Ctr
    Chapel Hill, North Carolina 27599-7295
    Metastatic Breast Cancer
    Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
    UNC Hospitals, The University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Lymphoma, Nonneoplastic Condition
    Dissemination of a Weight Management Program Among US Veterans
    Lineberger Comprehensive Cancer Center at UNC-CH
    Chapel Hill, North Carolina 27599-7294
    Body Weight
    Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
    University of North Carolina Hospital at Chapel Hill
    Chapel Hill, North Carolina 27599
    Graft-versus-Host Disease, Immune System Disorders
    Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Advanced Pancreatic Cancer
    A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma
    UNC Lineberger Comprehensive Cancer Center / University of North Carolina
    Chapel Hill, North Carolina 27599
    Disease, Hodgkin
    Apremilast in the Treatment of Moderate to Severe Acne
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Acne
    Safety and Efficacy of LCL161 in Patients With Solid Tumors
    UNC/ Lineberger Comprehensive Cancer Center Dept. of LinbergerCancerCtr(2)
    Chapel Hill, North Carolina 27599-7295
    Advanced Solid Tumors
    Pounds Off Digitally (POD): The Use of Podcasting and Mobile Media to Promote Weight Loss
    UNC-Chapel Hill Weight Research Center
    Chapel Hill, North Carolina 27599
    Obesity, Overweight
    Collection of Bone Marrow From Donors Treated With or Without Filgrastim
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Healthy, no Evidence of Disease
    Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
    University of North Carolina, Chapel Hill
    Chapel Hill, North Carolina 27599
    Heparin Induced Thrombocytopenia
    Trisenox® in Women With Metastatic Endometrial Cancer
    North Carolina Cancer Hosptial, UNC
    Chapel Hill, North Carolina 27599
    Endometrial Carcinoma
    Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Crohn's Disease
    Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1
    University of North Carolina, Chapel Hill
    Chapel Hill, North Carolina 27599
    Healthy Men Age 50 Who Are Considering PSA Screening
    Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
    UNC - CH Department of Surgery
    Chapel Hill, North Carolina 27599-7211
    Liver Cancer
    A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
    University of North Carolina, Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Renal Cell Carcinoma
    A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
    University of North Carolina at Chapel Hill

    Trial Locations
    University of North Carolina at Chapel Hill
    University of North Carolina at Chapel Hill Hospital
    Psoriasis
    Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer
    GTx Investigative Site
    Chapel Hill, North Carolina 27514
    Prostate Cancer
    Curcumin Pharmacokinetics
    UNC Department of Family Medicine
    Chapel Hill, North Carolina 27599
    Comparative Multidose Pharmacokinetics
    Curcumin Biomarkers
    UNC Department of Family Medicine
    Chapel Hill, North Carolina 27599
    Colorectal Cancer
    Facebook-based Physical Activity Intervention for Young Adult Cancer Survivors: the FITNET Randomized Pilot Study
    Lineberger Comprehensive Cancer Center at UNC-CH
    Chapel Hill, North Carolina 27599-7294
    Physical Activity
    E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Advanced or Metastatic Solid Tumors, Previously Untreated Gastric Cancer
    Phase II, Dose Finding Study of GTx-758
    GTx Investigative Site
    Chapel Hill, North Carolina 27514
    Prostate Cancer
    Testing the Efficacy of an Online Social Network Intervention to Increase Social Support for Physical Activity
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Cardiovascular Disease, Cancer, Obesity
    Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
    Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Multiple Myeloma
    Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation
    Unc Aids Crs (3201)
    Chapel Hill, North Carolina 27516
    HIV-1 Infection
    PRESENCE 2: Predicting Sedentary Entertainment Choices and Effects
    UNC Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina
    Obesity, Physical Activity
    Examining Adolescent Assessment, Feedback, Incentive, and Exchange (AFIX) in North Carolina
    Cervical Cancer-Free North Carolina
    Chapel Hill, North Carolina 27599
    Adolescent Health Services, Immunization
    Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast Cancer
    Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Breast Neoplasms
    Online Study of Colorectal Cancer and Prostate Cancer Screening Decision Making
    Cecil G. Sheps Center for Health Services Research
    Chapel Hill, North Carolina 27599
    Colorectal Cancer, Colon Cancer, Prostate Cancer
    Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Gliosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma
    Reliability of Hertel Exophthalmometer Measurements
    UNC Kittner Eye Center
    Chapel Hill, North Carolina 27599
    Standardization of Hertel Measurements
    Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT
    University of North Carolina, Chapel Hill
    Chapel Hill, North Carolina 27599
    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)
    trūFreeze® Spray Cryotherapy Patient Registry
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Barrett Esophagus, Esophageal Dysplasia, Esophageal Neoplasm, Esophageal Stenosis, Bronchial Neoplasm, Stenosis of Bronchus or Trachea, Central Airway Cancer
    The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Chronic Hepatitis C, Chronic Hepatitis B
    chemQbiosciences:Manual Liquid Based Cytology
    University of North Carolina Hospitals
    Chapel Hill, North Carolina 27599
    Cervical Dysplasia, Cervical Cancer
    Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors
    Lineberger Comprehensive Cancer Center/ University of North Carolina
    Chapel Hill, North Carolina 27599
    Sedentary Lifestyle, Breast Neoplasms, Survival Rate (Survivorship)
    A Prospective Evaluation of the Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Colorectal Cancer
    University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Advanced Colorectal Cancer
    Brief Intervention to Create Smoke-Free Homes Policies in Low-Income Households: North Carolina Effectiveness Trial
    University of North Carolina, Chapel Hill
    Chapel Hill, North Carolina 27599
    Chronic Disease